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doi:10.1016/j.jtcvs.2007.06.023bjectives: Radial artery vasospasm remains a potential cause of early graft failure
fter coronary bypass graft surgery, despite pretreatment with -adrenergic or
alcium channel blockers. We examined the roles of isoprostanes and prostanoid
eceptors selective for thromboxane A2 in the vasoconstriction of human radial
rteries.
ethods: Human radial arterial segments were pretreated intraoperatively with
erapamil/papaverine or nitroglycerine/phenoxybenzamine, or not treated. In the
aboratory, we measured isometric contractions in ring segments, vasoconstriction
n pressurized segments, and changes in [Ca2] and K currents in single cells.
esults: Although phenoxybenzamine eliminated adrenergic responses, the isopros-
ane 15-F2t-IsoP and 2 closely related E-ring molecules (15-E1t-IsoP and 15-E2t-
soP) still evoked powerful contractions; 15-E2t-IsoP was approximately 10-fold
ore potent than the other 2 agents. Responses were mediated through thromboxane
eceptors because they were sensitive to ICI-192605. Furthermore, they were
ensitive to the Rho-kinase inhibitors Y-27632 or H-1152 (both 105 mol/L) or to
yclopiazonic acid (which depletes the internal Ca2 pool), but not to nifedipine. In
ingle cells, 15-E2t-IsoP elevated [Ca2]i and suppressed K current.
onclusions: Isoprostanes accumulate after coronary artery bypass graft surgery, yet
one of the currently available antispasm treatments for radial artery grafts is
ffective against isoprostane-induced vasoconstriction. It is imperative that more
pecific treatment strategies be developed. We found that isoprostane responses in
adial arteries are mediated by prostanoid receptors selective for thromboxane A2
ith activation of Rho-kinase and release of Ca2. Pretreatment of radial artery
rafts with Rho-associated kinase inhibitors may potentially reduce postoperative
raft spasm. Clinical studies to test this are indicated.
 
he long-term benefits of arterial conduits in coronary artery bypass 
(CABG) surgery are well established.1,2 Radial artery (RA) grafts have be
used frequently because of their versatile applications, easy handling, and
elatively simple harvesting with low incidences of postoperative complication3-5
owever, the relatively more muscular nature of the RA grafts makes them more
usceptible to mechanical and pharmacologic stimulations,6 which usually result i
asoconstriction (although the actual postsurgical incidence of this is unclear). In its
ost severe form, the entire RA graft can close off as the result of graft spasm. The
recise mechanism of RA graft spasm is still not well understood: The strategies
eveloped to treat it have largely been empirical and based on hypothetic extrapo-
ations from other tissues, and have not succeeded in preventing RA spasm com-
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CSPletely. Therefore, there is a need to better understand
echanisms underlying perioperative RA spasm.
The CABG operation is essentially an ischem
eperfusion injury that is known to set the stage fo
roduction of free radicals that attack membrane lip
eading in part to the production of metabolites know
soprostanes.7 The latter can be produced while the lip
re in free form, as well as when they are still est
ithin the membrane (to be released even weeks late
hospholipases). In fact, isoprostanes are widely used
arkers of oxidative stress. Several groups have n
ocumented their accumulation in the blood a
ABG.8-10 However, our group and many others h
hown isoprostanes to be powerfully bioactive;7,11 for
xample, they are powerful vasoconstrictor agents act
hrough prostanoid receptors selective for thromboxa
2 (TP receptors). Here, we compared the responsiven
f human radial arteries with 3 different isoprostanes 
sed a variety of pharmacologic tools to characterize
ignaling pathway(s) by which they act. We examined
ffects of several different isoprostanes on tension 
essel diameter in whole tissues, as well as cyto
Ca2  ] and K currents in single cells. Altogether, 
ocument powerful excitatory effects of the isoprosta
n the human RA. Concurrently, we considered the 
tive efficacies of 2 different pharmacologic strateg
urrently used within the operative suite aimed at 
enting vasospasm after CABG surgery.
aterials and Methods
reparation of Arterial Tissues
ll experimental procedures were approved by the ethics com
ee of St Joseph’s Healthcare and Hamilton Health Sciences.
RA tissues were harvested as pedicles (with veins and p
erial fat) using the traditional open technique and treated
mmersion for 30 minutes at room temperature in Ringer’s la
ontaining either verapamil plus papaverine (3.25 and 0.25 
L, respectively) or phenoxybenzamine plus nitroglycerine (
nd 0.2 mg/mL, respectively). A third set of tissues were set
ithout undergoing any such pretreatment (control). RA tiss
hat were not used in the surgical procedure were then transp
n ice to the laboratory where the loosely adherent adipose
Abbreviations and Acronyms
CABG  coronary artery bypass graft
KCl  potassium chloride
NE  norepinephrine
RA  radial artery
ROCK  Rho-associated kinase
TP receptors prostanoid receptors selective for
thromboxane A2onnective tissues were removed and the arterial vessels were cut(
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s
d
e
nto ring segments approximately 3 to 4 mm long, and then
mmediately or stored overnight for use the following day.
issue Bath Technique
adial arterial rings were mounted in standard 2.5-mL mu
aths containing Krebs–Ringer buffer (see below for comp
ion); a stretch of 1 g was imposed perpendicularly to the ax
he lumen, and isometric contractions were recorded as we 
escribed.12 These were equilibrated for 1 hour by challeng
ith 60 mmol/L KCl 3 times, after which responsivenes
drenergic stimuli and/or to U-46619 (a thromboxane A2 ana-
ogue) was assessed. Where indicated, some tissues were left i
uscle baths overnight (at 37°C and with continuous bubbling
he same assessment the following day.
ideo-monitored Perfusion System
adial arterial segments were kept overnight in Dulbecco’s M
fied Eagle Medium at 37°C. The segments were cannulate
oth ends and mounted in a video-monitored perfusion sy
Living Systems Instrumentation Inc, Burlington, Vt). The ar
as bathed in an 8-mL chamber containing Krebs–Ringer b
continuously bubbled) on the stage of an inverted microscope
uperfused externally at a rate of 2 mL/min by Krebs–R
uffer (at 37°C). Distal and proximal pressures were monito
nd the mean arterial pressure was controlled distally to 85 m
y a pressure servocontrol system. Images were acquired usi
igital camera (30 frames/sec) and passed through a video di
ion analyzer that derives overall vessel diameter on a fr
y-frame basis. Arteries were equilibrated for 1 hour in K
inger’s buffer (37°C), replaced at 15-minute intervals, c
enged twice with 60 mmol/L KCl, and then challenged with
soprostanes 15-F2t-IsoP and 15-E2t-IsoP before and after treat-
ent with pharmacologic blockers.
ingle Cell Studies
ndividual myocytes were dissociated from human RA rings using
ollagenase, elastase, and papain/dithiothreitol, as we described
reviously.13,14 Cytosolic concentrations of [Ca2]i were recorded
sing a custom-built confocal microscope, and membrane currents
ere recorded using the standard patch-clamp electrophysiologic
echnique, both as described previously.13-16
olutions and Chemicals
rebs–Ringer buffer contained 116 mmol/L of NaCl, 4.2 mmol/L
f KCl, 2.5 mmol/L of CaCl2, 1.6 mmol/L of NaH2PO4, 1.2
mol/L of MgSO4, 22 mmol/L of NaHCO3, and 11 mmol/L of
-glucose, bubbled to maintain the pH at 7.4. L-NNA (104
ol/L) and indomethacin (105 mol/L) were also added to prevent
he generation of nitric oxide and cyclo-oxygenase metabolites of
rachidonic acid, respectively. Chemicals were obtained from
igma Chemical Company (St Louis, Mo), except for U46619
Cayman Chemical Company; Ann Arbor, Mich), ICI 192605
Tocris; Ellisville, Mo), H-1152 (Calbiochem; distributed by VWR
anlab, Mississauga, Ontario), and fluo-4 AM and pluronic acid
Molecular Probes; distributed by Invitrogen Canada, Burlington,
ntario). Pharmacologic tools were prepared in distilled waternorepinephrine [NE]; phenylephrine; phentolamine, H-1152), eth-
ary 2008
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Pnol, or dimethyl sulfoxide (isoprostanes, U46619; nifedipi
yclopiazonic acid; Y-27632; ICI 192,605).
ata Analysis
ll data are reported as mean  standard error of the mean;
efers to the number of patients. Statistical comparisons were 
sing 2-way analysis of variance with Newman–Keuls post 
est.
esults
esponsiveness to Nonspecific Constrictor Stimulus
otassium chloride (KCl) acts primarily by depolariz
he membrane and triggering voltage-dependent Ca2 
nflux.17 By using tissues that had been treated intra-
ratively with various pharmacologic regimens, we co
ared KCl-evoked contractions on the day they w
ollected and after overnight incubation in the mu
aths with maintained warming and bubbling. Figur
ummarizes the mean magnitudes of those responses. 
esponses in the verapamil/papaverine-treated tissu
ere significantly smaller than in the control, whe
hose of the phenoxybenzamine/nitroglycerine-treate
issues were not. Also, no statistically significant dif
nce was observed between day 1 and day 2 with
iven group.
esponsiveness to Receptor-specific Stimuli
e also assessed the responsiveness of the tissues t
-adrenoreceptor agonist (NE) or to several isoprosta
15-F2t-IsoP and 2 closely related E-ring molecules 15-1t-
soP and 15-E2t-IsoP) added in 10-fold increments in -
ulative fashion. Tissue strips that received no pharma
ogic treatment in the surgical suite exhibited d
ependent increases in tension in response to NE (Figu
). The maximal response to NE was approximately eq
lent in magnitude to that of the KCl responses evok
he same tissues. Likewise, in tissues that had been tr
n the surgical suite with verapamil and papaverine, 
voked concentration-dependent contractions that were n
ignificantly different in magnitude from the untreated 
ues (Figure 2, A). Tissues pretreated with the -adrenocep-
or antagonist phenoxybenzamine, however, exhibited 
ppreciable response to NE (Figure 2, A). Nonetheless, th
atter did exhibit powerful concentration-dependent tensi
esponses to all 3 isoprostanes. Figure 2, B summarizes the
ean concentration-response relationships so obtained (n
). All 3 isoprostanes evoked contractions that were app
mately double the amplitude of the KCl-evoked respo
ith respect to potency, the tissues were approxima
0-fold more responsive to 15-E2t-IsoP than to the other
ompounds, with a half-maximally effective concentrati
f 3  107 mol/L. Because isoprostanes generally exe
heir actions through TP receptors, we tested the effec
he TP-receptor antagonist ICI 192605 (106 mol/L; n  5) a
The Journal of Thoracica
,
n
f
r GR32191B (106 mol/L; n  3): Responsiveness to th
ost potent isoprostane, 15-E2t-IsoP, was abrogated b
R32191 and abolished by ICI 192605 (Figure 2, C; n 5).
his responsiveness was not affected, however, by sup
entation of -adrenoceptor blockade using phentolamin
105 mol/L; n  4). Likewise in pressurized arteries, both
5-E2t-IsoP and 15-F1t-IsoP caused concentration-depen-
ent decreases in diameter (Figure 3; n  4), with 15-E2t-
soP showing greater potency than 15-F2t-IsoP (statistically
ignificant different at 107 mol/L), which were blocked by
CI 192,605 (Figure 4; n  4).
harmacologic Sensitivity of 15-E2t-IsoP–evoked
asoconstrictor Responses
ext, we examined the sensitivity of 15-E2t-IsoP–evoked
esponses to pretreatment with a variety of pharmacologic
lockers; the data are summarized in Figures 4 (pressur
rterial segments) and 5 (isometric contractions). Respon
o 15-E2t-IsoP were completely unaffected by nifedipine
105 mol/L; n  7; blocker of voltage-dependent Ca2-
hannels). Cyclopiazonic acid (105 mol/L; n  7; depletes
he internal Ca2 pool), on the other hand, partially reduced
he magnitude of the responses, particularly those evoked by
icromolar concentrations of isoprostane (statistically sig-
ificant only at 105 mol/L 15-E1t-IsoP). Isoprostanes may
ncrease the Ca2 sensitivity of the contractile apparatus via
igure 1. Responsiveness to KCl. Contractile responses to KCl (60
mol/L) were assessed in ring segments treated intraoperatively
ith verapamil plus papaverine (n  12) or phenoxybenzamine
lus nitroglycerine (n  18), or not at all (n  11); see “Materials
nd Methods” for details. Responses were assessed on the same
ay the tissue was excised (open bars) and in the same tissues
n the following day (filled bars). KCl, Potassium chloride.ctivation of ROCK.12,18 To assess the involvement of this
and Cardiovascular Surgery ● Volume 135, Number 1 133
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CSPathway, we used 2 different ROCK inhibitors, Y-27
nd H-1152. Both significantly attenuated isoprostane-
uced contractions (Figure 4).
luorimetry
uman radial arterial myocytes loaded with the Ca2-indi-
ator dye fluo-4 and studied using confocal fluorime
echniques exhibited a substantial increase in fluoresce
bove baseline on application of 15-E2t-IsoP (105 mol/L).
igure 6, A illustrates a representative example, and Figu
, B compares the mean responses to isoprostane or
affeine in 11 cells (n  4).
atch-clamp Electrophysiology
epolarizing pulses (from 60 to  50 mV, 10-mV incre
ents) from a holding potential of 70 mV evoked ou
ardly rectifying K currents at potentials greater then 40
V. A representative recording is given in Figure 7.
lication of 15-E2t-IsoP (105 mol/L, through a m-
ropuffer) did not increase the holding current but 
tatistically significantly suppress the K currents: at a
otential of30 mV, these were reduced by 22.6% 6.1%
n  7).
iscussion
efore their use in CABG surgery, human RA segments are
outinely pretreated perioperatively with pharmacologic
ools selected for their ability to inhibit perio- or postoper-
tive vasoconstriction. We compared the responsiveness of
uman RA tissues pretreated using 2 common intraopera-
igure 3. Isoprostane-evoked constrictions under auxotonic con-
itions. Mean changes in arterial diameter of human RA pressur-
zed to 85 mm Hg and challenged with increasing concentrations
f either 15-F2t-IsoP or 15-E2t-IsoP, added in cumulative fashion (n
4).igure 2. Responsiveness to receptor-specific stimuli. Mean con-
entration-response relationships for NE or 3 different isopros-
anes (15-F2t-IsoP, 15-E1t-IsoP, and 15-E2t-IsoP) in human RA. A,
E-evoked responses in tissues that did not receive intraopera-
ive pretreatment (filled circles) or those pretreated with vera-
amil/papaverine (open circles) or phenoxybenzamine plus nitro-
lycerine (filled triangles). B, Isoprostane-evoked responses in
issues pretreated intraoperatively with phenoxybenzamine/nitro-
lycerine. C, Effects of the TP-receptor blockers ICI 192605 (106
ol/L; n  5) or GR 32191B (106 mol/L; n  3) or the -adreno-
eptor blocker phentolamine (n  4) against responses to 15-E2t-
soP in phenoxybenzamine/nitroglycerine-treated tissues. KCl,
otassium chloride.ive regimens for their responsiveness to isoprostanes. We
ary 2008
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Pound the arteries to be highly responsive to the E-ring
soprostane 15-E2t-IsoP and approximately 10-fold less re-
ponsive to 2 other structurally similar isoprostanes: 15-F2t-
soP (possesses a hydroxyl group on the central carbon ring
nstead of a ketone group) and 15-E1t-IsoP (possesses 1
ouble bond in the fatty acid side chain rather than 2). This
igh degree of selectivity among the isoprostanes is sug-
estive of a receptor-mediated mechanism. We found the
soprostane-evoked response to be abolished by the TP-
eceptor blockers ICI-192605 and GR 32191A.
We also probed the signaling pathways underlying these
igure 4. Pharmacologic characterization of the role of ROCK in
soprostane-evoked responses. A, Mean percentage change in
iameter to increasing concentrations of 15-E2t-IsoP (n  11)
n the absence or presence of Y-27632 (105 mol/L, 15 minutes, n
5), H-1152 (106 mol/L, 15 minutes, n  6), and ICI-192605 (106
ol/L, 20 minutes, n 4). B, Mean percentage change in diameter
o increasing concentration of 15-F2t-IsoP (n  8) in the absence
r presence of Y-27632 (105 mol/L, 15 minutes, n  5) and
CI-192,605 (106 mol/L, 20 minutes, n  4).esponses. TP receptors can mediate altered Ca2 sensitiv- l
The Journal of Thoracicty via the RhoA/ROCK signaling pathway, as well as
elease of internally sequestered Ca2.7 We found 15-E2t-
soP responses to be highly sensitive to the ROCK inhibi-
ors Y-27632 and H-1152.19 Although recent studie
howed that Y-27632 can inhibit some protein kinase C
soforms,20 this is not true of the novel and more sele
OCK inhibitor, H-1152.21 We also found 15-E1t-IsoP
voked an increase in [Ca2]i. Although it also partially
uppressed K currents, which might have a depolarizing
nfluence on the membrane, the contractions were not sen-
itive to a blocker of voltage-dependent Ca2 channels
nifedipine). On the other hand, the contractions were sup-
ressed by an inhibitor of the internal Ca2 pump (cyclo-
iazonic acid). We conclude that this E-ring isoprostane
timulates human RA through TP receptors coupled to
elease of internally sequestered Ca2 and activation of the
hoA/ROCK signaling pathway.
These data are relevant to currently used clinical practice
n CABG surgery vis-a-vis the use of pharmacologic treat-
ents to reduce graft vasoreactivity with the intent of pre-
enting postsurgical vasospasm. A standard approach is to
retreat the graft materials with known vasodilators, such as
a2 channel blockers (eg, verapamil), nitric oxide donors
eg, nitroglycerine), or papaverine (mechanism of action is
oorly understood). However, none of these are irreversible:
hese are easily diluted from the graft material once coro-
ary blood flow is reestablished and/or are metabolized to
igure 5. Pharmacologic characterization of the Ca2 pools un-
erlying responses to 15-E2t-IsoP. Mean concentration–response
elationships for 15-E2t-IsoP– evoked changes in tension in RA
ings bathed in the absence or presence of nifedipine (105 mol/L;
 7) or cyclopiazonic acid (105 mol/L; n  7). CPA, Cyclopia-
onic acid; KCl, potassium chloride.ess reactive or nonreactive derivatives. Given the important
and Cardiovascular Surgery ● Volume 135, Number 1 135
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CSPole played by the sympathetic innervation in control of
asomotor tone, it was thought that treatment of the graft
aterial with adrenoceptor blockers such as phentolamine
esylate (Regitine; Novartis, Basel, Switzerland) or phe-
oxybenzamine might be beneficial.22-26 We confirm her
hat any effect of pretreating the human RA with verapamil
nd nitroglycerine is easily and quickly lost, whereas pre-
reatment with the irreversible -blocker phenoxyben-
amine seems to be somewhat more persistent, lasting at
east 1 day and several washes. However, this study none-
heless shows that phenoxybenzamine-pretreated vessels
an still respond to other non-adrenergic excitatory stimuli:
timulation of TP receptors with isoprostanes evoked sub-
tantial contractions (in fact, even larger than those evoked
y -adrenergic stimuli) irrespective of whether the tissues
ad been pretreated. Isoprostanes are produced in large
mounts by peroxidative attack of lipid membranes and
ave been shown to accumulate to substantial levels after a
ide variety of conditions of oxidative stress,7,27 including
ABG surgery.8-10 They can be released immediately d-
ng the period of oxidative stress or formed while still
sterified within the plasmalemma and be released at a later
ime by phospholipases.28 Also, additional isoprostane pro-
uction and release can occur days or weeks after surgery if
erfusion is not optimal and oxidative stress recurs. Given
hat the heart and the tissue graft itself are the source of
hese isoprostanes, local intra-tissue concentrations would
ikely be much higher than those measured in the circulating
lood. This may account for the postsurgical spasm some-
imes seen after such surgeries.
A large body of data attest to the importance of voltage-
ependent Ca2 influx in some aspects of vascular smooth
uscle reactivity, and oral Ca2 channel blockers remain a
rimary agent for the prevention of postoperative RA
pasm. However, the effectiveness of intraoperative topical
Figure 7. Electrophysiologic response
to isoprostane. In a freshly enzymati-
cally dissociated human RA cell, step
depolarizations (60 mV to 50 mV, in
10-mV increments, from a holding po-
tential of 70 mV) evoked outward
currents (left) that were suppressed by
15-E2t-IsoP (10
5 mol/L) (right).Figure 6. Fluorimetric responses to 15-E2t-IsoP. A, In an enzymat-
ically dissociated human RA cell loaded with the Ca2-indicator
dye fluo-4, 15-E2t-IsoP (10
5 mol/L) elevated [Ca2]i in a concen-
tration-dependent manner. B, Mean changes in fluorescence
(percent above baseline) in response to 15-E2t-IsoP (10
5 mol/L in
perfusion medium) or caffeine (10 mmol/L, applied by pressure
ejection from micropipette).ary 2008
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Pa2-channel blockade has never been proven. Our find
hat nifedipine has little effect against the contract
voked by stimulation of TP receptors or -adrenoceptors
uggest this approach will have little usefulness in prev
ng RA spasm. We believe our findings warrant cli
tudies that test the usefulness of TP receptor blockers 
erioperatively on the graft itself or postsurgically a
escue therapy once vasospasm manifests itself. These h
lready been assayed for use in several other clinical 
itions, and it is interesting that thromboxane rece
lockers are generally found to be much more effective
hromboxane synthesis inhibitors.29,30 This difference is no
xpected if thromboxanes are involved but is entirely 
istent with isoprostane pharmacology. Alternatively, o
ata also indicate the potential usefulness of ROCK in
tors, which would also be effective against the spasmog
ctions of other agonists (eg, endothelin and angioten
nd may increase the activation31 and expression32 of en-
othelial nitric oxide synthase.
Our data also document that pretreatment of the 
aterials with phenoxybenzamine completely abrogat
heir responsiveness to adrenergic agonists even days a
retreatment and after numerous washings. This find
ould suggest that adrenergic agonists can in fact be 
ostsurgically to elevate overall systemic blood press
eg, as an inotrope in the event of shock), because the
ill be unable to respond while the peripheral vascula
xhibits the normal vasopressor response.
This study now sets the stage for several novel res
irections. First, further investigation into the pharmaco
etics of thromboxanes and isoprostanes after CABG
eeded. Also, the efficacies of alternative approaches to
erioperative pharmacologic treatment of the graft mater
nd management of the patient need to be evaluated,
ther interventions for postsurgical vasospasm should 
eveloped. The surgeon’s concern should not be so m
oward postsurgical adrenergic responsiveness of t
rafted material but rather to more powerful vasoconstri
timuli, such as thromboxanes and isoprostanes.
onclusions
e find the human RA to be highly responsive to iso
anes, which act through TP receptors to stimulate 
elease of internally sequestered Ca2 and RhoA/ROCK
ctivities. Given that isoprostanes can accumulate to s
tantial levels after CABG surgery,8-10 it is imperative tha
trategies aimed at treating or preventing postsurgical vaso-
pasm consider the blockade of this signaling pathway.
The authors thank Mary-Helen Blackall for her assistance in
oordinating the transporting of radial arterial specimens from the
perating suite to the laboratory.
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